-
-
-
-
-
-
-
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Ligand Pharma (LGND) Offers $15M to Acquire Assets of Novan (NOVN)
-
-
-
-
-
-
-
Ligand Reports First Quarter 2021 Financial Results
-
-
-
-
-
-
-
Roth Capital Impressed by Speed of Ligand (LGND) Capitalizing on OMT Acquisition; Affirms at 'Buy'
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

